EdgarLookup

ZyVersa Therapeutics, Inc. — 8-K Filings

47 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ZyVersa Therapeutics, Inc. (ZVSA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ZyVersa Therapeutics, Inc. has filed 47 8-K documents with the SEC since 2021. To view all SEC filings by ZyVersa Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 25-NSE 3 4 424B3 424B4 424B5 425 8-A12B 8-A12B/A 8-K 8-K/A ARS CERT CORRESP DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM POS EX PRE 14A S-1 S-1/A S-3 S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001493152-26-008994 Mar 5, 2026 Feb 27, 2026
8-K 8-K 0001493152-25-025966 Dec 3, 2025 Dec 2, 2025
8-K 8-K 0001493152-25-024273 Nov 19, 2025
8-K 8-K 0001493152-25-018156 Oct 15, 2025 Oct 10, 2025
8-K 8-K 0001493152-25-013968 Sep 18, 2025 Sep 14, 2025
8-K 8-K 0001641172-25-021100 Jul 28, 2025 Jul 25, 2025
8-K 8-K 0001641172-25-019856 Jul 16, 2025 Jul 15, 2025
8-K 8-K 0001641172-25-018403 Jul 9, 2025 Jul 8, 2025
8-K 8-K 0001641172-25-016388 Jun 25, 2025 Jun 24, 2025
8-K 8-K 0001641172-25-014895 Jun 12, 2025 Jun 11, 2025
8-K 8-K 0001641172-25-013038 May 30, 2025 May 27, 2025
8-K 0001641172-25-003034 Apr 7, 2025 Apr 4, 2025
8-K 0001493152-25-009571 Mar 7, 2025 Mar 4, 2025
8-K 0001493152-24-045371 Nov 14, 2024
8-K 0001493152-24-043754 Nov 6, 2024 Nov 5, 2024
8-K 0001493152-24-043066 Oct 30, 2024 Oct 29, 2024
8-K 0001493152-24-036453 Sep 16, 2024
8-K 0001493152-24-029868 Aug 1, 2024
8-K 0001493152-24-015938 Apr 25, 2024
8-K 0001493152-24-015041 Apr 17, 2024
8-K 0001493152-24-009437 Mar 8, 2024 Mar 6, 2024
8-K 0001493152-24-008508 Mar 1, 2024 Feb 29, 2024
8-K 0001493152-23-045948 Dec 22, 2023
8-K 0001493152-23-044400 Dec 11, 2023 Dec 6, 2023
8-K 0001493152-23-043170 Nov 30, 2023
8-K 0001493152-23-041884 Nov 17, 2023 Nov 14, 2023
8-K 0001493152-23-039162 Nov 2, 2023 Oct 31, 2023
8-K 0001493152-23-032553 Sep 14, 2023 Sep 13, 2023
8-K 0001493152-23-032103 Sep 8, 2023 Sep 1, 2023
8-K 0001493152-23-029441 Aug 18, 2023 Aug 7, 2023
8-K 0001493152-23-025596 Jul 26, 2023 Jun 5, 2023
8-K 0001493152-23-020803 Jun 12, 2023 Jun 9, 2023
8-K 0001493152-23-018355 May 19, 2023 May 17, 2023
8-K 0001493152-23-016793 May 15, 2023 May 12, 2023
8-K 0001493152-23-010560 Apr 3, 2023
8-K 0001493152-23-007281 Mar 10, 2023 Mar 9, 2023
8-K 0001493152-23-006692 Mar 3, 2023 Feb 28, 2023
8-K 0001493152-23-002761 Jan 27, 2023
8-K 0001493152-23-000844 Jan 6, 2023 Jan 5, 2023
8-K 0001493152-22-036510 Dec 23, 2022
8-K 0001493152-22-035258 Dec 13, 2022 Dec 12, 2022
8-K CURRENT REPORT 0001213900-22-078742 Dec 9, 2022 Dec 8, 2022
8-K CURRENT REPORT 0001213900-22-040769 Jul 22, 2022 Jul 20, 2022
8-K CURRENT REPORT 0001213900-22-007004 Feb 11, 2022
8-K CURRENT REPORT 0001213900-22-005920 Feb 8, 2022
8-K CURRENT REPORT 0001213900-21-068082 Dec 30, 2021 Dec 23, 2021
8-K CURRENT REPORT 0001213900-21-067374 Dec 23, 2021 Dec 20, 2021